Marchiafava-Bignami disease

Longitudinal MR imaging and MR spectroscopy study

Anna Gambini, Andrea Falini, Lucia Moiola, Giancarlo Comi, Giuseppe Scotti

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

A case of Marchiafava-Bignami disease was serially evaluated with MR imaging and MR spectroscopy at 1, 2, 4, and 11 months after the onset of symptoms. The first MR imaging study showed extensive abnormal signal intensity of the corpus callosum without macroscopic changes; a diagnosis of Marchiafava-Bignami disease was made, and vitamin therapy was initiated. Follow-up studies showed progressive reduction of signal intensity abnormalities and residual callosal atrophy. MR spectroscopy revealed progressive reduction of the N-acetylaspartate:creatine ratio, with partial recovery in the last study, and a normalization of the choline:creatine ratio, which was initially slightly increased. Lactate was detectable during the subacute phase and was replaced by lipids after 4 months. This study confirmed the role of MR imaging in diagnosing Marchiafava-Bignami disease and particularly the value of MR spectroscopy in focusing the pathogenesis of the disease, monitoring its evolution and changes related to therapy.

Original languageEnglish
Pages (from-to)249-253
Number of pages5
JournalAmerican Journal of Neuroradiology
Volume24
Issue number2
Publication statusPublished - Feb 2003

Fingerprint

Marchiafava-Bignami Disease
Magnetic Resonance Spectroscopy
Creatine
Corpus Callosum
Choline
Vitamins
Atrophy
Lactic Acid
Lipids
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Marchiafava-Bignami disease : Longitudinal MR imaging and MR spectroscopy study. / Gambini, Anna; Falini, Andrea; Moiola, Lucia; Comi, Giancarlo; Scotti, Giuseppe.

In: American Journal of Neuroradiology, Vol. 24, No. 2, 02.2003, p. 249-253.

Research output: Contribution to journalArticle

@article{a7529911f91a4d7cb18dadbffb41b794,
title = "Marchiafava-Bignami disease: Longitudinal MR imaging and MR spectroscopy study",
abstract = "A case of Marchiafava-Bignami disease was serially evaluated with MR imaging and MR spectroscopy at 1, 2, 4, and 11 months after the onset of symptoms. The first MR imaging study showed extensive abnormal signal intensity of the corpus callosum without macroscopic changes; a diagnosis of Marchiafava-Bignami disease was made, and vitamin therapy was initiated. Follow-up studies showed progressive reduction of signal intensity abnormalities and residual callosal atrophy. MR spectroscopy revealed progressive reduction of the N-acetylaspartate:creatine ratio, with partial recovery in the last study, and a normalization of the choline:creatine ratio, which was initially slightly increased. Lactate was detectable during the subacute phase and was replaced by lipids after 4 months. This study confirmed the role of MR imaging in diagnosing Marchiafava-Bignami disease and particularly the value of MR spectroscopy in focusing the pathogenesis of the disease, monitoring its evolution and changes related to therapy.",
author = "Anna Gambini and Andrea Falini and Lucia Moiola and Giancarlo Comi and Giuseppe Scotti",
year = "2003",
month = "2",
language = "English",
volume = "24",
pages = "249--253",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "2",

}

TY - JOUR

T1 - Marchiafava-Bignami disease

T2 - Longitudinal MR imaging and MR spectroscopy study

AU - Gambini, Anna

AU - Falini, Andrea

AU - Moiola, Lucia

AU - Comi, Giancarlo

AU - Scotti, Giuseppe

PY - 2003/2

Y1 - 2003/2

N2 - A case of Marchiafava-Bignami disease was serially evaluated with MR imaging and MR spectroscopy at 1, 2, 4, and 11 months after the onset of symptoms. The first MR imaging study showed extensive abnormal signal intensity of the corpus callosum without macroscopic changes; a diagnosis of Marchiafava-Bignami disease was made, and vitamin therapy was initiated. Follow-up studies showed progressive reduction of signal intensity abnormalities and residual callosal atrophy. MR spectroscopy revealed progressive reduction of the N-acetylaspartate:creatine ratio, with partial recovery in the last study, and a normalization of the choline:creatine ratio, which was initially slightly increased. Lactate was detectable during the subacute phase and was replaced by lipids after 4 months. This study confirmed the role of MR imaging in diagnosing Marchiafava-Bignami disease and particularly the value of MR spectroscopy in focusing the pathogenesis of the disease, monitoring its evolution and changes related to therapy.

AB - A case of Marchiafava-Bignami disease was serially evaluated with MR imaging and MR spectroscopy at 1, 2, 4, and 11 months after the onset of symptoms. The first MR imaging study showed extensive abnormal signal intensity of the corpus callosum without macroscopic changes; a diagnosis of Marchiafava-Bignami disease was made, and vitamin therapy was initiated. Follow-up studies showed progressive reduction of signal intensity abnormalities and residual callosal atrophy. MR spectroscopy revealed progressive reduction of the N-acetylaspartate:creatine ratio, with partial recovery in the last study, and a normalization of the choline:creatine ratio, which was initially slightly increased. Lactate was detectable during the subacute phase and was replaced by lipids after 4 months. This study confirmed the role of MR imaging in diagnosing Marchiafava-Bignami disease and particularly the value of MR spectroscopy in focusing the pathogenesis of the disease, monitoring its evolution and changes related to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0037329419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037329419&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 249

EP - 253

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 2

ER -